PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2005 December; 6(4): E634–E640.
Published online 2005 December 12. doi:  10.1208/pt060479
PMCID: PMC2750612

Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution

Abstract

The aims of this study are (1) to compare the disintegration efficiency, and (2) to develop a discriminating test model for the 3 classes of superdisintegrants represented by Ac-Di-Sol, Primojel, and Polyplasdone XL10. Using a digital video camera to examine the disintegration process of tablets containing the same wt/wt percentage concentration of the disintegrants, Ac-Di-Sol was found to disintegrate tablets rapidly into apparently primary particles; Primojel also apparently disintegrated tablets into primary particles but more slowly; Polyplasdone XL10 disintegrated tablets rapidly but into larger masses of aggregated particles. The differences in the size distribution generated in the disintegrated tablets likely contribute to the drug dissolution rate differences found for aspirin tablets with similar disintegration rates. The aspirin tablet matrix is proposed as a model formulation for disintegrant efficiency comparison and performance consistency testing for quality control purposes.

Keywords: Superdisintegrants, aspirin tablet, disintegration, dissolution test

Full Text

The Full Text of this article is available as a PDF (192K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Bi YX, Sunada H, Yonezawa Y, Danjo K. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 1999;25:571–581. doi: 10.1081/DDC-100102211. [PubMed] [Cross Ref]
2. Sallam E, Ibrahim H, Abu Dahab R, Shubair M, Khalil E. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant. Drug Dev Ind Pharm. 1998;24:501–507. doi: 10.3109/03639049809085650. [PubMed] [Cross Ref]
3. Bi Y, Sunada H, Yonezawa Y, et al. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 1996;44:2121–2127. [PubMed]
4. Massimo G, Catellani PL, Santi P, et al. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics. Pharm Dev Technol. 2000;5:163–169. doi: 10.1081/PDT-100100531. [PubMed] [Cross Ref]
5. Caramella C, Colombo P, Conte U, et al. Water uptake and disintegrating force measurements: towards a general understanding of disintegration mechanisms. Drug Dev Ind Pharm. 1986;12:1749–1766. doi: 10.3109/03639048609042607. [Cross Ref]
6. Johnson JR, Wang LH, Gordon MS, Chowhan ZT. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution. J Pharm. Sci. 1991;80:469–471. doi: 10.1002/jps.2600800514. [PubMed] [Cross Ref]
7. Pandit JK, Tripathi MK, Babu RJ. Effect of tablet disintegrants on the dissolution stability of nalidixic acid tablets. Pharmazie. 1997;52:538–540.
8. Sakr A, Bose M, Menon A. Comparative effectiveness of superdisintegrants on the characteristics of directly compressed triamterene hydrochlorothiazide tablets. Pharm Ind. 1993;55:953–957.
9. Chen CR, Cho SL, Lin CK, Lin YH, Chiang ST, Wu HL. Dissolution difference between acidic and neutral media of acetaminophen tablets containing a super disintegrant and a soluble excipient. II. Chem Pharm Bull (Tokyo). 1998;46:478–481. [PubMed]
10. Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech. 2005;6:E120–E126. doi: 10.1208/pt060119. [PMC free article] [PubMed] [Cross Ref]
11. Gordon MS, Rudraraju VS, Dani K, Chowhan ZT. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci. 1993;82:220–226. doi: 10.1002/jps.2600820222. [PubMed] [Cross Ref]
12. United States Pharmacopeia, 27th revision. Rockville, MD: USP Convention, Inc; 2004. pp. 2302–2302.
13. Rizk S, Barthelemy C, Duru C, Guyot-Herman AM. Investigation on a new modified USP xanthan with tablet-disintegrating properties. Drug Dev Ind Pharm. 1997;23:19–26.
14. Chang RK, Shinwari M, Leonzio M, Wu LS, Hussain MA. Evaluation of the disintegrant properties for an experimental, crosslinked polyalkylammonium polymer. Int J Pharm. 1998;173:87–92. doi: 10.1016/S0378-5173(98)00218-X. [Cross Ref]
15. Colombo P, Conte U, Caramella C, Geddo M, Manna A. Disintegrating force as a new formulation parameter. J Pharm Sci. 1984;73:701–705. doi: 10.1002/jps.2600730531. [PubMed] [Cross Ref]
16. Zhao N, Augsburger LL. On the development of a disintegrating functionality test for superdisintegrants. AAPS PharmSci. 2003;5:M1256–M1256.
17. Shah U, Augsburger LL. Evaluation of the functional equivalence of crospovidone NF from different sources. 2. Standard performance test. Pharm Dev Technol. 2001;6:419–430. doi: 10.1081/PDT-100002250. [PubMed] [Cross Ref]
18. Zhao N. Investigation of Super Disintegrant Functionality and Development of Discriminating Test Methods [dissertation] Baltimore, MD: University of Maryland; 2005.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists